Press Release: Palisade Capital Management Welcomes Chris Mashia to Small Cap Core and Smid Cap Core Equity Strategies
Palisade Capital Management Welcomes Chris Mashia to Small Cap Core and Smid Cap Core Equity Strategies PR Newswire FORT LEE, N.J., April 29, 2024 FORT LEE, N.J., April 29, 2024 /PRNewswire/ -- Pal
Dow Jones18:14 ET
ING, PALI and FNCH Among Pre-market Losers
Seeking AlphaApr 24 08:45 ET
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
BenzingaApr 23 13:53 ET
KOPN, BTCM and CETX Among Mid-day Movers
Seeking AlphaApr 23 13:16 ET
Dow Jumps Over 200 Points; US Services PMI Falls In April
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.The Dow traded up 0.60% to 38,470.94 while the NASDAQ rose 1.44% to 15,673.22. The S&P 500
BenzingaApr 23 12:21 ET
Why Palisade Bio Stock Is Up Today
Palisade Bio, Inc. (NASDAQ:PALI) shares are trading higher Tuesday after the company entered into a collaboration with Strand Life Sciences.The Details:Palisade Bio said its collaboration with Strand
BenzingaApr 23 12:06 ET
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers
Seeking AlphaApr 23 10:00 ET
Palisade Bio, Strand Life Sciences Team up on Colitis Drug Research
Seeking AlphaApr 23 09:28 ET
Express News | Palisade Bio Shares Rise 23% Premarket as Co Enters Into a Partnership With Strand Life Sciences
Moomoo 24/7Apr 23 09:10 ET
Express News | Palisade Bio Shares Are Trading Higher After the Company's Entered a Collaboration With Strand Life Sciences
Moomoo 24/7Apr 23 08:34 ET
Express News | Palisade Bio Enters Collaboration With Strand Life Sciences Aimed At Advance Precision Medicine Approach; Collaboration Provides Palisade Bio Access To Advanced Bioinformatics Tools
Moomoo 24/7Apr 23 08:33 ET
Express News | Palisade Bio Enters Into Strategic Collaboration With Strand Life Sciences to Advance Precision Medicine Approach
Moomoo 24/7Apr 23 08:30 ET
Palisade Bio Enters Into Strategic Collaboration With Strand Life Sciences to Advance Precision Medicine Approach
– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving milestone in Palisade Bio's mission to redefine UC trea
Palisade BioApr 23 00:00 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)
TipRanksApr 17 11:30 ET
Looking Into Palisade Bio's Recent Short Interest
Palisade Bio's (NYSE:PALI) short percent of float has risen 756.82% since its last report. The company recently reported that it has 27 thousand shares sold short, which is 3.77% of all regular shares
BenzingaApr 17 10:45 ET
Express News | Maxim Group Maintains Buy on Palisade Bio, Adjusts Price Target To $22.5 (Reverse Stock Split 1:15)
Moomoo 24/7Apr 16 13:27 ET
Palisade Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/16/2024 238.89% Maxim Group $22.5 → $22.5 Maintains Buy 11/17/2023 -77.41% Maxim Group → $1.5 Upgrades
BenzingaApr 16 13:22 ET
JAGX, BSGM and SXTC Among Mid-day Movers
Seeking AlphaApr 16 12:40 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersPalisade Bio (NASDAQ:PALI) stock increased by 65.1% to $6.87 during Tuesday's regular session. The company's market cap stands at $5.8 million. China SXT Pharmaceuticals (NASDAQ:SXTC) shares ro
BenzingaApr 16 12:31 ET
Why Palisade Bio Stock Is Soaring Today
Palisade Bio, Inc. (NASDAQ:PALI) shares are trading higher Tuesday after the company announced the completion of its analysis evaluating ex-vivo bioactivation of PALI-2108.The Details:Palisade Bio sai
BenzingaApr 16 11:47 ET
No Data
No Data